Associated Genetic Biomarkers
Associated Diseases
Associated Pathways


Location [1]
MAP kinase signaling, Kinase fusions
Protein [2]
Serine/threonine-protein kinase B-raf
Synonyms [1]
B-raf, NS7, B-RAF1, RAFB1, BRAF1

BRAF (B-Raf proto-oncogene, serine/threonine kinase) is a gene that encodes the protein serine/threonine-protein kinase B-raf. BRAF is involved in many cellular processes, including cell proliferation, differentiation, and transcriptional regulation. Mutant BRAF has been implicated in the pathogenesis of several cancers, including melanoma, non-small cell lung cancer, colorectal cancer, papillary thyroid cancer, and ovarian cancer (PMID: 12068308).

BRAF is altered in 5.83% of all cancers with melanoma, colorectal adenocarcinoma, non-small cell lung carcinoma, thyroid gland neoplasm, and breast carcinoma having the greatest prevalence of alterations [3].

BRAF GENIE Cases - Top Diseases

The most common alterations in BRAF are BRAF Mutation (7.58%), BRAF Codon 600 Missense (4.49%), BRAF V600E (4.25%), BRAF Amplification (0.27%), and BRAF G469A (0.20%) [3].

BRAF GENIE Cases - Top Alterations

Biomarker-Directed Therapies

Significance of BRAF in Diseases

Melanoma +

Colorectal Carcinoma +

Non-Small Cell Lung Carcinoma +

Hairy Cell Leukemia +

Erdheim-Chester Disease +

Mature B-Cell Lymphoma/Leukemia +

Malignant Solid Tumor +

Multiple Myeloma +

Glioma +

Cancer +

Non-Hodgkin Lymphoma +

Breast Carcinoma +

Thyroid Gland Papillary Carcinoma +

Cutaneous Melanoma +

Lymphoma +

Gastric Carcinoma +

Pancreatic Carcinoma +

Thyroid Gland Carcinoma +

Thyroid Gland Adenocarcinoma +

Colorectal Adenocarcinoma +

Head And Neck Squamous Cell Carcinoma +

Gastrointestinal Stromal Tumor +

Ovarian Carcinoma +

Histiocytic And Dendritic Cell Neoplasm +

Pancreatic Ductal Adenocarcinoma +

Cholangiocarcinoma +

Neuroblastoma +

Squamous Cell Lung Carcinoma +

Adenocarcinoma Of The Gastroesophageal Junction +

Esophageal Carcinoma +

Solid Neoplasm +

Germ Cell Tumor +

Histiocytosis +

Neurofibromatosis Type 1 +

Papillary Craniopharyngioma +

Melanoma Of Unknown Primary +

Langerhans Cell Histiocytosis +

Thyroid Gland Undifferentiated (Anaplastic) Carcinoma +

Poorly Differentiated Thyroid Gland Carcinoma +

Colon Carcinoma +

Mucosal Melanoma +

Small Intestinal Adenocarcinoma +

Rectal Carcinoma +

Urothelial Carcinoma +

Bladder Carcinoma +

Endometrial Carcinoma +

Malignant Glioma +

Glioblastoma +

Malignant Salivary Gland Neoplasm +

Lung Carcinoma +

Chronic Lymphocytic Leukemia +

B-Cell Non-Hodgkin Lymphoma +

Thymic Carcinoma +

Small Cell Lung Carcinoma +

Hepatocellular Carcinoma +

Cervical Squamous Cell Carcinoma +

Esophageal Squamous Cell Carcinoma +

Prostate Carcinoma +

Pancreatic Adenocarcinoma +

Nasopharyngeal Carcinoma +

Malignant Peripheral Nerve Sheath Tumor +

Head And Neck Carcinoma +

Soft Tissue Sarcoma +

Thyroid Gland Follicular Carcinoma +

Renal Cell Carcinoma +

Ameloblastoma +

Hepatobiliary Neoplasm +

Hodgkin Lymphoma +

Lip And Oral Cavity Carcinoma +

Malignant Laryngeal Neoplasm +

Metastatic Malignant Neoplasm In The Brain +

Nasal Cavity And Paranasal Sinus Carcinoma +

Neurofibroma +

Oropharyngeal Carcinoma +

Rhabdoid Tumor +

Rhabdomyosarcoma +

Schwannoma +

Splenic Diffuse Red Pulp Small B-Cell Lymphoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015.

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.